Roth JA - Search Results

1

Stakeholder perspectives on a risk-benefit framework for genetic testing.

Roth JA, Garrison LP Jr, Burke W, Ramsey SD, Carlson R, Veenstra DL. Roth JA, et al. Public Health Genomics. 2011;14(2):59-67. doi: 10.1159/000290452. Epub 2010 Apr 20. Public Health Genomics. 2011. PMID: 20407215 Free PMC article.

2

A formal risk-benefit framework for genomic tests: facilitating the appropriate translation of genomics into clinical practice.

Veenstra DL, Roth JA, Garrison LP Jr, Ramsey SD, Burke W. Veenstra DL, et al. Among authors: roth ja. Genet Med. 2010 Nov;12(11):686-93. doi: 10.1097/GIM.0b013e3181eff533. Genet Med. 2010. PMID: 20808229 Free PMC article.

3

Getting our priorities straight: a novel framework for stakeholder-informed prioritization of cancer genomics research.

Esmail LC, Roth J, Rangarao S, Carlson JJ, Thariani R, Ramsey SD, Veenstra DL, Deverka P. Esmail LC, et al. Genet Med. 2013 Feb;15(2):115-22. doi: 10.1038/gim.2012.103. Epub 2012 Oct 4. Genet Med. 2013. PMID: 23037935 Free PMC article.

4

Value-of-information analysis within a stakeholder-driven research prioritization process in a US setting: an application in cancer genomics.

Carlson JJ, Thariani R, Roth J, Gralow J, Henry NL, Esmail L, Deverka P, Ramsey SD, Baker L, Veenstra DL. Carlson JJ, et al. Med Decis Making. 2013 May;33(4):463-71. doi: 10.1177/0272989X13484388. Med Decis Making. 2013. PMID: 23635833 Free PMC article.

5

Genetic risk factors for major bleeding in patients treated with warfarin in a community setting.

Roth JA, Boudreau D, Fujii MM, Farin FM, Rettie AE, Thummel KE, Veenstra DL. Roth JA, et al. Clin Pharmacol Ther. 2014 Jun;95(6):636-43. doi: 10.1038/clpt.2014.26. Epub 2014 Feb 6. Clin Pharmacol Ther. 2014. PMID: 24503627 Free PMC article.

6

Design of a cost-effectiveness analysis alongside a randomized trial of transplantation using umbilical cord blood versus HLA-haploidentical related bone marrow in advanced hematologic cancer.

Roth JA, Bensink ME, O'Donnell PV, Fuchs EJ, Eapen M, Ramsey SD. Roth JA, et al. J Comp Eff Res. 2014 Mar;3(2):135-44. doi: 10.2217/cer.13.95. J Comp Eff Res. 2014. PMID: 24645687 Free PMC article. Clinical Trial.

7

Cost-effectiveness of a 14-gene risk score assay to target adjuvant chemotherapy in early stage non-squamous non-small cell lung cancer.

Roth JA, Billings P, Ramsey SD, Dumanois R, Carlson JJ. Roth JA, et al. Oncologist. 2014 May;19(5):466-76. doi: 10.1634/theoncologist.2013-0357. Epub 2014 Apr 7. Oncologist. 2014. PMID: 24710309 Free PMC article.

8

Economic return from the Women's Health Initiative estrogen plus progestin clinical trial: a modeling study.

Roth JA, Etzioni R, Waters TM, Pettinger M, Rossouw JE, Anderson GL, Chlebowski RT, Manson JE, Hlatky M, Johnson KC, Ramsey SD. Roth JA, et al. Ann Intern Med. 2014 May 6;160(9):594-602. doi: 10.7326/M13-2348. Ann Intern Med. 2014. PMID: 24798522 Free PMC article.

9

The short-term cost-effectiveness of once-daily liraglutide versus once-weekly exenatide for the treatment of type 2 diabetes mellitus in the United States.

Wang B, Roth JA, Nguyen H, Felber E, Furnback W, Garrison LP. Wang B, et al. Among authors: roth ja. PLoS One. 2015 Apr 7;10(4):e0121915. doi: 10.1371/journal.pone.0121915. eCollection 2015. PLoS One. 2015. PMID: 25849542 Free PMC article.

10

Alcohol misuse, genetics, and major bleeding among warfarin therapy patients in a community setting.

Roth JA, Bradley K, Thummel KE, Veenstra DL, Boudreau D. Roth JA, et al. Pharmacoepidemiol Drug Saf. 2015 Jun;24(6):619-27. doi: 10.1002/pds.3769. Epub 2015 Apr 8. Pharmacoepidemiol Drug Saf. 2015. PMID: 25858232 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,251 results

Search Page

Filters